Results
1
Companies which are potentially undervalued and in an acceptable financial position.
1 companies
UCB
Market Cap: €50.2b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
€263.90
7D
-4.0%
1Y
93.6%